Business Description
Alibaba Health Information Technology Ltd
ISIN : BMG0171K1018
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 137.2 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.09 | |||||
Interest Coverage | 67.28 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.85 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 36.2 | |||||
3-Year EBITDA Growth Rate | 95.1 | |||||
3-Year FCF Growth Rate | -26.6 | |||||
3-Year Book Growth Rate | 38.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.52 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.79 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.73 | |||||
9-Day RSI | 25.51 | |||||
14-Day RSI | 30.59 | |||||
6-1 Month Momentum % | -24.68 | |||||
12-1 Month Momentum % | -40.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.01 | |||||
Quick Ratio | 2.68 | |||||
Cash Ratio | 2.32 | |||||
Days Inventory | 30.23 | |||||
Days Sales Outstanding | 7.41 | |||||
Days Payable | 60.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.8 | |||||
Shareholder Yield % | 0.12 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.22 | |||||
Operating Margin % | 1.17 | |||||
Net Margin % | 2.88 | |||||
FCF Margin % | 2.16 | |||||
ROE % | 5.27 | |||||
ROA % | 3.9 | |||||
ROIC % | 5.02 | |||||
ROC (Joel Greenblatt) % | 1017.16 | |||||
ROCE % | 5.52 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 39.55 | |||||
PE Ratio without NRI | 50.19 | |||||
Price-to-Owner-Earnings | 1309.98 | |||||
PS Ratio | 1.11 | |||||
PB Ratio | 2.04 | |||||
Price-to-Tangible-Book | 2.19 | |||||
Price-to-Free-Cash-Flow | 51.41 | |||||
Price-to-Operating-Cash-Flow | 50.41 | |||||
EV-to-EBIT | 31.16 | |||||
EV-to-Forward-EBIT | -18.11 | |||||
EV-to-EBITDA | 29.35 | |||||
EV-to-Forward-EBITDA | -18.6 | |||||
EV-to-Revenue | 0.95 | |||||
EV-to-Forward-Revenue | 1.08 | |||||
EV-to-FCF | 45.6 | |||||
Price-to-Projected-FCF | 1.8 | |||||
Price-to-Median-PS-Value | 0.03 | |||||
Price-to-Graham-Number | 2.21 | |||||
Price-to-Net-Current-Asset-Value | 3.18 | |||||
Price-to-Net-Cash | 4.83 | |||||
Earnings Yield (Greenblatt) % | 3.21 | |||||
FCF Yield % | 1.61 |